Feedback / Questions
vobramitamab duocarmazine (MGC018) - MacroGenics
https://www.globenewswire.com/news-release/2024/05/09/2879138/0/en/MacroGenics-Provides-Update-on-Corporate-Progress-First-Quarter-2024-Financial-Results-and-Interim-TAMARACK-Phase-2-Study-Data.html
May 9, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next